Contact Us
Home Jazz Pharmaceuticals Announces Presentation at the UBS Global Life Sciences Conference in New York on September 20

News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Jazz Pharmaceuticals Announces Presentation at the UBS Global Life Sciences Conference in New York on September 20

September 16, 2011
PDF Version

PALO ALTO, Calif., Sept. 16, 2011 /PRNewswire via COMTEX/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the company will make a presentation at the UBS Global Life Sciences Conference in New York on Tuesday, September 20, 2011 at 9:30 a.m. Eastern Time. Company management will provide a business and financial update.

A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at http://www.jazzpharmaceuticals.com/. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archived version of webcast will be available for at least one week on the Investors section of the company's website at http://www.jazzpharmaceuticals.com/.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information, see http://www.jazzpharmaceuticals.com/.

SOURCE Jazz Pharmaceuticals, Inc.